We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Qiagen's HPV Test Patent Not Infringed: Fed. Circ.

Law360 (April 1, 2009, 12:00 AM EDT) -- A federal appeals court has upheld a district court’s finding that Third Wave Technologies Inc. did not infringe Qiagen NV unit Digene Corp.’s patent covering a test for the cancer-causing human papillomavirus, as well as the court's dismissal of Third Wave’s antitrust cross-claims.

The U.S. Court of Appeals for the Federal Circuit on Wednesday determined that the U.S. District Court for the Western District of Wisconsin did not err in its claim constructions that deflated Qiagen’s patent case and was correct in granting Qiagen summary judgment...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.